SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-24-018797
Filing Date
2024-05-30
Accepted
2024-05-30 21:17:52
Documents
1
Period of Report
2024-05-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3852
  Complete submission text file 0001437749-24-018797.txt   5306
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Issuer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address NO.10, UNIT 1, LIJING VILLA TIANZHU, SHUNYI DISTRICT BEIJING F4 101316
Business Address
Zheng Yongxiang (Reporting) CIK: 0001910375 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33678 | Film No.: 241007326